https://www.businesswire.com/news/home/20220109005059/en/Bayer-and-Mammoth-Biosciences-to-Collaborate-on-Novel-Gene-Editing-Technology
Bayer and Mammoth Biosciences to Collaborate on Novel Gene Editing Technology
Mammoth Biosciences partners with Bayer to develop gene-editing therapies for five in vivo indications, first focusing on liver-targeted diseases.
mammoth biosciencesgene editingbayer
https://mammoth.bio/
Mammoth Biosciences
Reading and writing the code of life.
mammothbiosciences
https://www.businesswire.com/news/home/20220124005618/en/Mammoth-Biosciences-Receives-FDA-Emergency-Use-Authorization-for-First-CRISPR-based-High-Throughput-COVID-19-Test
Mammoth Biosciences Receives FDA Emergency Use Authorization for First CRISPR-based High-Throughput...
Mammoth Biosciences receives emergency use authorization from the FDA for the first CRISPR-based high-throughput COVID-19 test.
emergency use authorization
https://www.distractify.com/p/a-mammoth-endeavor-colossal-biosciences-merges-artificial-intelligence-with-showbiz-to-revive-extinct-species
A Mammoth Endeavor: Colossal Biosciences Merges Artificial Intelligence With Showbiz to Revive...
Jul 18, 2025 - Colossal Biosciences, powered by AI and amplified by Hollywood's megaphone, is proving that the story of extinction doesn't have to be a final chapter.
colossal biosciences
https://www.businesswire.com/news/home/20211026005322/en/Vertex-and-Mammoth-Biosciences-Announce-Collaboration-to-Develop-In-Vivo-Gene-Editing-Therapies-for-Serious-Diseases
Vertex and Mammoth Biosciences Announce Collaboration to Develop In Vivo Gene-Editing Therapies for...
Mammoth Biosciences advances CRISPR platform, partnering with Vertex Pharmaceuticals to develop in vivo gene-editing therapies for serious diseases.
https://www.biospace.com/press-releases/mammoth-biosciences-to-present-at-43rd-annual-j-p-morgan-healthcare-conference
Mammoth Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference - BioSpace
j p morgan